Company / SG&A per Share
BioAge Labs, Inc. SG&A per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.78
FY2025
5-year range
$0.78 / $8.68
FY2023-FY2025
Trend
-56.6%
vs FY2024
Sector context
#138 of 210
Health Care
What the data says
At $0.78, BioAge Labs, Inc.'s sg&a per share ranks #73 of 210 in the Health Care sector. Improved from $8.68 to $0.78 over the past 2 years.
Based on SEC 10-K filings.
0.78 in FY2025.
Improved from $8.68 to $0.78 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#73 of 210 in Health CareTop 34% of 210This company $0.78 Sector average $40.75
▼
-98.1% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 56.6% year-over-year.
- Ranks #138 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.75 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.78 | -56.6% |
| FY2024 | $1.79 | -79.4% |
| FY2023 | $8.68 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026